TWO SIGMA INVESTMENTS, LP - AERIE PHARMACEUTICALS INC ownership

AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 157 filers reported holding AERIE PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.60 and the average weighting 0.3%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of AERIE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$719,000
+221.0%
47,529
+59.3%
0.00%
+100.0%
Q2 2022$224,000
-55.2%
29,829
-45.7%
0.00%0.0%
Q1 2022$500,000
+287.6%
54,967
+199.4%
0.00%
Q4 2021$129,000
-95.5%
18,358
-89.9%
0.00%
-100.0%
Q2 2021$2,898,000
-30.4%
181,018
-22.3%
0.01%
-36.4%
Q1 2021$4,164,000
+716.5%
233,029
+2299.1%
0.01%
+450.0%
Q2 2017$510,000
-95.6%
9,713
-96.2%
0.00%
-94.9%
Q1 2017$11,482,000253,1900.04%
Other shareholders
AERIE PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
LEVIN CAPITAL STRATEGIES, L.P. 1,373,542$15,658,0001.56%
DAFNA Capital Management LLC 289,040$3,295,0000.87%
Integral Health Asset Management, LLC 250,000$2,850,0000.82%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 193,266$2,203,0000.80%
PFM Health Sciences, LP 2,182,684$24,883,0000.73%
DCF Advisers, LLC 136,501$1,556,0000.69%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,977,020$33,938,0000.66%
NEXPOINT ASSET MANAGEMENT, L.P. 309,778$3,532,0000.61%
Rhenman & Partners Asset Management AB 750,000$8,550,0000.60%
RICE HALL JAMES & ASSOCIATES, LLC 1,232,600$14,052,0000.52%
View complete list of AERIE PHARMACEUTICALS INC shareholders